Alto Neuroscience, Inc. (ANRO)
ANRONYSEBiotechnology: Pharmaceutical Preparations
$28.61
+0.8100 (+2.91%) today
Closed, Nov 10, 4:00 PM ET
- Market cap
- $1.12bn
- P/E
- –
- EPS, last 4 quarters
- $-2.42
- Dividend yield
- –
- Day range
- –
- 52-week range
- $10.80 to $37.48
- Average volume
- –
- Previous close
- $27.80
Analysts
5 coveringBuy5 buy, 0 hold, 0 sell
Targets a year out average $45.67, +59.6% from here
Earnings
next estimate $-0.6000Next report Nov 11, 2026
Sep 2025
+21.2%
Dec 2025
+19.6%
Mar 2026
-42.9%
Jun 2026
+8.4%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$14.95m | -$17.05m | -$27.14m | -$29.13m |
| Net income | -$14.18m | -$16.18m | -$26.24m | -$27.64m |
News
8 latest- Here's Why You Should Add ANRO Stock to Your Portfolio NowZacks · Oct 14, 2026
- Are Medical Stocks Lagging Cardinal Health (CAH) This Year?Zacks · Oct 13, 2026
- Biotech Stocks At 52-Week Highs - BIVI +22%, XNCR, ANRO, HAE, ACAD RTTNews · Aug 13, 2026
- Biotech Stocks At 52-Week Highs - DCTH +22% On Q2 Results, ANRO, COAG, MNPR, NRIX RTTNews · Aug 7, 2026
- Alto Prices Direct Offering Worth $100 Mln At $26.48 Per Share RTTNews · Jul 15, 2026
- Biotech Stocks Hit 52-Week Highs - TOI, IKT, ANRO, ELV, PRVA RTTNews · Jul 15, 2026
- Stocks Recover on Hopes Strait of Hormuz Could Soon ReopenBarchart · Apr 6, 2026
- Stocks Pare Losses on Hormuz ReportBarchart · Apr 2, 2026
The company
Alto Neuroscience (NYSE: ANRO) is a clinical-stage biopharmaceutical company on a mission to transform the treatment of mental health conditions through a deeper understanding of the brain. Leveraging its proprietary Precision Psychiatry Platform, Alto is advancing a broad pipeline of novel medicines for depression, schizophrenia, and other neuropsychiatric disorders. The Company's lead program, ALTO-207, is in late-stage clinical development for treatment-resistant depression.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- altoneuroscience.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.